ecopipam has been researched along with 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol in 3 studies
Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol) | Trials (3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol) | Recent Studies (post-2010) (3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol) |
---|---|---|---|---|---|
147 | 18 | 34 | 105 | 0 | 18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acquas, E; Di Chiara, G | 2 |
Ikeda, K; Ikejiri, M; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Ogi, Y | 1 |
3 other study(ies) available for ecopipam and 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol
Article | Year |
---|---|
Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
Topics: Acetylcholine; Animals; Benzazepines; Benzopyrans; Dopamine; Dopamine Agonists; Dopamine Antagonists; Feedback; Male; Neostriatum; Oxazines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1999 |
Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine.
Topics: Acetylcholine; Benzazepines; Benzopyrans; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Microdialysis; Neostriatum; Neurons; Oxazines; Quinpirole; Receptors, Dopamine D1 | 2001 |
The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Topics: Acetamides; Animals; Apomorphine; Benzamides; Benzazepines; Benzopyrans; Blinking; Callithrix; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Male; Models, Animal; Oxazines; Piperazines; Pyridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4 | 2016 |